β-(1-Pyrenyl)-L-alanine
Need Assistance?
  • US & Canada:
    +
  • UK: +

β-(1-Pyrenyl)-L-alanine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
L-Amino Acids
Catalog number
BAT-007511
CAS number
87147-90-8
Molecular Formula
C19H15NO2
Molecular Weight
289.33
β-(1-Pyrenyl)-L-alanine
IUPAC Name
(2S)-2-amino-3-pyren-1-ylpropanoic acid
Synonyms
H-Ala(1-Pyn)-OH; H-Ala(1-Pyrenyl)-OH; 1-Pyrenylalanine; 1-PYA; 3-(1-Pyrenyl)-L-alanine; (2S)-2-amino-3-pyren-1-ylpropanoic acid; L-1-pyrenylalanine; L-3-(1-pyrenyl)alanine
Appearance
Crystalline powder
Purity
97%
Density
1.377 g/cm3 (Predicted)
Boiling Point
531.9 °C at 760 mmHg
Storage
Store at RT
InChI
InChI=1S/C19H15NO2/c20-16(19(21)22)10-14-7-6-13-5-4-11-2-1-3-12-8-9-15(14)18(13)17(11)12/h1-9,16H,10,20H2,(H,21,22)/t16-/m0/s1
InChI Key
VTMOPDBUZPBOPL-INIZCTEOSA-N
Canonical SMILES
C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CC(C(=O)O)N

β-(1-Pyrenyl)-L-alanine, a versatile fluorescent amino acid derivative, finds a myriad of applications in biochemical and biophysical studies. Here are the key applications of β-(1-Pyrenyl)-L-alanine presented with high perplexity and burstiness:

Protein Folding Studies: By incorporating β-(1-Pyrenyl)-L-alanine into proteins, researchers unlock a window into their intricate folding dynamics. Monitoring fluorescence changes offers profound insights into the complex pathways and stability of protein folding. This knowledge is invaluable for unraveling the enigmatic nature of protein misfolding diseases like Alzheimer's and Parkinson's.

Protein-Protein Interactions: Capitalizing on the unique fluorescent properties of β-(1-Pyrenyl)-L-alanine, researchers use it as a potent probe to explore protein-protein interactions. Once introduced into interacting partners, fluorescence becomes a dynamic tool for tracking binding events and dissociation kinetics. This innovative technique yields crucial data on the affinity and specificity governing protein interactions, shedding light on molecular interactions.

Membrane Protein Studies: By employing β-(1-Pyrenyl)-L-alanine to label membrane proteins, scientists delve into their localization and dynamics within the lipid bilayer. The fluorescence emitted by β-(1-Pyrenyl)-L-alanine offers a non-invasive method to visualize the real-time behavior of membrane proteins. This approach is indispensable for unraveling the roles and regulations of membrane-bound receptors and transporters, providing insights into cellular processes.

Site-Specific Labeling: Through sophisticated genetic code expansion techniques, β-(1-Pyrenyl)-L-alanine is strategically incorporated into proteins at specific sites. This precise labeling of amino acid residues enables in-depth structural and functional analyses, unraveling the functions of individual residues in protein activity. Such an approach is vital for designing next-generation protein-based therapeutics and advancing our understanding of protein structure and function.

1. Phospholamban binds in a compact and ordered conformation to the Ca-ATPase
Jinhui Li, Yijia Xiong, Diana J Bigelow, Thomas C Squier Biochemistry. 2004 Jan 20;43(2):455-63. doi: 10.1021/bi035424v.
Mutagenesis and cross-linking measurements have identified specific contact interactions between the cytosolic and the transmembrane sequences of phospholamban (PLB) and the Ca-ATPase, and in conjunction with the high-resolution structures of PLB and the Ca-ATPase, have been used to construct models of the PLB-ATPase complex, which suggest that PLB adopts a more extended structure within this complex. To directly test these predictions, we have used fluorescence resonance energy transfer to measure the average conformation and heterogeneity between chromophores covalently bound to the transmembrane and cytosolic domains of PLB reconstituted in proteoliposomes. In the absence of the Ca-ATPase, the cytosolic domain of PLB assumes a wide range of structures relative to the transmembrane sequence, which can be described using a model involving a Gaussian distribution of distances with an average distance (Rav) of less than 21 A and a half-width (HW) of 36 A. This conformational heterogeneity of PLB is consistent with the 10 structures resolved by NMR for the C41F mutant of PLB in organic cosolvents. In contrast, PLB bound to the Ca-ATPase assumes a unique and highly ordered conformation, where Rav = 14.0 +/- 0.3 A and HW = 3.7 +/- 0.6 A. The small spatial separation between the bound chromophores on PLB is inconsistent with an extended conformation of bound PLB in current models. Thus, to satisfy known interaction sites of PLB and the Ca-ATPase, these findings suggest a reorientation of the nucleotide binding domain of the Ca-ATPase toward the bilayer surface to bring known PLB binding sites into close juxtaposition with residues near the amino-terminus of PLB. Induction of an altered conformation of the nucleotide binding domain of the Ca-ATPase by PLB binding is suggested to underlie the reduced calcium sensitivity associated with PLB inhibition of the pump.
2. Rearrangement of domain elements of the Ca-ATPase in cardiac sarcoplasmic reticulum membranes upon phospholamban phosphorylation
S Negash, S Huang, T C Squier Biochemistry. 1999 Jun 22;38(25):8150-8. doi: 10.1021/bi990599j.
Phospholamban (PLB) is a major target of the beta-adrenergic cascade in the heart, and functions to modulate rate-limiting conformational transitions involving the transport activity of the Ca-ATPase. To investigate structural changes within the Ca-ATPase that result from the phosphorylation of PLB by cAMP-dependent protein kinase (PKA), we have covalently bound the long-lived phosphorescent probe erythrosin isothiocyanate (Er-ITC) to cytoplasmic sequences within the Ca-ATPase. Under these labeling conditions, the Ca-ATPase remains catalytically active, indicating that observed changes in rotational dynamics reflect normal conformational transitions. Two major Er-ITC labeling sites were identified using electrospray ionization mass spectrometry (ESI-MS), corresponding to Lys464 and Lys650, which are respectively located within the phosphorylation and nucleotide binding domains of the Ca-ATPase. Frequency-domain phosphorescence measurements of the rotational dynamics of Er-ITC bound to these cytoplasmic sequences within the Ca-ATPase permit the resolution of the dynamic structure of individual domain elements relative to the overall rotational motion of the entire Ca-ATPase polypeptide chain. We observe a significant decrease in the rotational dynamics of Er-ITC bound to the Ca-ATPase upon phosphorylation of PLB by PKA, as evidenced by an increase in the residual anisotropy. These results suggest that phosphorylation of PLB results in a structural reorientation of the phosphorylation or nucleotide binding domains with respect to the membrane normal. In contrast, calcium activation of the Ca-ATPase in the presence of dephosphorylated PLB results in no detectable change in the rotational dynamics of Er-ITC, suggesting that calcium binding and PLB phosphorylation have distinct effects on the conformation of the Ca-ATPase. We suggest that PLB functions to alter the efficiency of phosphoenyzme formation following calcium activation of the Ca-ATPase by modulating the spatial arrangement between ATP bound in the nucleotide binding domain and Asp351 in the phosphorylation domain.
3. Phosphorylation by cAMP-dependent protein kinase modulates the structural coupling between the transmembrane and cytosolic domains of phospholamban
Jinhui Li, Diana J Bigelow, Thomas C Squier Biochemistry. 2003 Sep 16;42(36):10674-82. doi: 10.1021/bi034708c.
We have used frequency-domain fluorescence spectroscopy to investigate the structural linkage between the transmembrane and cytosolic domains of the regulatory protein phospholamban (PLB). Using an engineered PLB having a single cysteine (Cys(24)) derivatized with the fluorophore N-(1-pyrenyl)maleimide (PMal), we have used fluorescence resonance energy transfer (FRET) to measure the average spatial separation and conformational heterogeneity between PMal bound to Cys(24) in the transmembrane domain and Tyr(6) in the cytosolic domain near the amino terminus of PLB. In these measurements, PMal serves as a FRET donor, and Tyr(6) serves as a FRET acceptor following its nitration by tetranitromethane. The native structure of PLB is retained following site-directed mutagenesis and chemical modification, as indicated by the ability of the derivatized PLB to fully regulate the Ca-ATPase following their co-reconstitution. To assess how phosphorylation modulates the structure of PLB itself, FRET measurements were made following reconstitution of PLB in membrane vesicles made from extracted sarcoplasmic reticulum membrane lipids. We find that the cytosolic domain of PLB assumes a wide range of conformations relative to the transmembrane sequence, consistent with other structural data indicating the presence of a flexible hinge region between the transmembrane and cytosolic domains of PLB. Phosphorylation of Ser(16) by PKA results in a 3 A decrease in the spatial separation between PMal at Cys(24) and nitroTyr(6) and an almost 2-fold decrease in conformational heterogeneity, suggesting a stabilization of the hinge region of PLB possibly through an electrostatic linkage between phosphoSer(16) and Arg(13) that promotes a coil-to-helix transition. This structural transition has the potential to function as a conformational switch, since inhibition of the Ca-ATPase requires disruption of the secondary structure of PLB in the vicinity of the hinge element to permit association with the nucleotide binding domain at a site located approximately 50 A above the membrane surface. Following phosphorylation, the stabilization of the helical content in the hinge domain will disrupt this inhibitory interaction by reducing the maximal dimension of the cytosolic domain of PLB. Thus, stabilization of the structure of PLB following phosphorylation of Ser(16) is part of a switching mechanism, which functions to alter binding interactions between PLB and the nucleotide binding domain of the Ca-ATPase that modulates enzyme inhibition.
Online Inquiry
Verification code
Inquiry Basket